These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32342699)

  • 1. Development of a 3-Dimensional Prognostic Score for Patients With Symptomatic Peripheral Artery Disease: PAD
    Dopheide JF; Ramadani H; Adam L; Gahl B; Papac L; Veit J; Kaspar M; Schindewolf M; Baumgartner I; Drexel H
    Angiology; 2020 Aug; 71(7):658-665. PubMed ID: 32342699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase 10 is associated with disease severity and mortality in patients with peripheral arterial disease.
    Martinez-Aguilar E; Gomez-Rodriguez V; Orbe J; Rodriguez JA; Fernández-Alonso L; Roncal C; Páramo JA
    J Vasc Surg; 2015 Feb; 61(2):428-35. PubMed ID: 25441671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of disease distribution of lower extremity peripheral arterial disease.
    Chen Q; Shi Y; Wang Y; Li X
    Angiology; 2015 Mar; 66(3):211-8. PubMed ID: 24650949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality rates at 10 years are higher in diabetic than in non-diabetic patients with chronic lower extremity peripheral arterial disease.
    Mueller T; Hinterreiter F; Poelz W; Haltmayer M; Dieplinger B
    Vasc Med; 2016 Oct; 21(5):445-452. PubMed ID: 27067137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crural Index and extensive atherosclerosis of crural vessels are associated with long-term cardiovascular mortality in patients with symptomatic peripheral artery disease.
    Wickström JE; Jalkanen JM; Venermo M; Hakovirta HH
    Atherosclerosis; 2017 Sep; 264():44-50. PubMed ID: 28763728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on Mortality and Cardiovascular Events of Adherence to Guideline-Recommended Therapy 4 Years after Lower Extremity Arterial Revascularization.
    Thiney M; Della Schiava N; Ecochard R; Feugier P; Lermusiaux P; Millon A; Long A
    Ann Vasc Surg; 2018 Oct; 52():138-146. PubMed ID: 29777848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hospital discharge risk score for 1-year all-cause mortality or non-fatal cardiovascular events in patients with lower-extremity peripheral artery disease, with and without revascularisation.
    Pros N; Cambou JP; Aboyans V; Malloizel Delaunay J; Constans J; Lacroix P; Saint Lèbes B; Curaudeau E; Bura A
    Eur J Vasc Endovasc Surg; 2013 May; 45(5):488-96. PubMed ID: 23434110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of lower limbs' arterial calcification on the prevalence and severity of PAD in patients on hemodialysis.
    Ohtake T; Oka M; Ikee R; Mochida Y; Ishioka K; Moriya H; Hidaka S; Kobayashi S
    J Vasc Surg; 2011 Mar; 53(3):676-83. PubMed ID: 21211928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple biomarkers for mortality prediction in peripheral arterial disease.
    Amrock SM; Weitzman M
    Vasc Med; 2016 Apr; 21(2):105-12. PubMed ID: 26762418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.
    Sigvant B; Hasvold P; Kragsterman B; Falkenberg M; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2017 Aug; 66(2):507-514.e1. PubMed ID: 28433332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YKL-40 levels increase with declining ankle-brachial index and are associated with long-term cardiovascular mortality in peripheral arterial disease patients.
    Höbaus C; Tscharre M; Herz CT; Pesau G; Wrba T; Koppensteiner R; Schernthaner GH
    Atherosclerosis; 2018 Jul; 274():152-156. PubMed ID: 29783062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease.
    Urbonaviciene G; Martin-Ventura JL; Lindholt JS; Urbonavicius S; Moreno JA; Egido J; Blanco-Colio LM
    Atherosclerosis; 2011 Dec; 219(2):892-9. PubMed ID: 21962403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evidence-based score to detect prevalent peripheral artery disease (PAD).
    Duval S; Massaro JM; Jaff MR; Boden WE; Alberts MJ; Califf RM; Eagle KA; D'Agostino RB; Pedley A; Fonarow GC; Murabito JM; Steg PG; Bhatt DL; Hirsch AT;
    Vasc Med; 2012 Oct; 17(5):342-51. PubMed ID: 22711750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of ischemic events in patients with peripheral arterial disease design, baseline characteristics and 2-year results an observational study.
    Blinc A; Kozak M; Sabovic M; Božic M; Stegnar M; Poredoš P; Kravos A; Barbic-Žagar B; Pohar Perme M; Stare J;
    Int Angiol; 2011 Dec; 30(6):555-66. PubMed ID: 22233617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten Year Mortality in Different Peripheral Arterial Disease Stages: A Population Based Observational Study on Outcome.
    Sartipy F; Sigvant B; Lundin F; Wahlberg E
    Eur J Vasc Endovasc Surg; 2018 Apr; 55(4):529-536. PubMed ID: 29478910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower limb arterial calcification (LLAC) scores in patients with symptomatic peripheral arterial disease are associated with increased cardiac mortality and morbidity.
    Chowdhury MM; Makris GC; Tarkin JM; Joshi FR; Hayes PD; Rudd JHF; Coughlin PA
    PLoS One; 2017; 12(9):e0182952. PubMed ID: 28886041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of mortality in patients with coronary or peripheral artery disease following the first vascular intervention.
    Pereg D; Elis A; Neuman Y; Mosseri M; Segev D; Granek-Catarivas M; Lishner M; Hermoni D
    Coron Artery Dis; 2014 Jan; 25(1):79-82. PubMed ID: 24128887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Biomarkers to Predict Cardiovascular Outcome in Patients With Peripheral Artery Disease: A Systematic Review and Meta-Analysis.
    Kremers B; Wübbeke L; Mees B; Ten Cate H; Spronk H; Ten Cate-Hoek A
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2018-2032. PubMed ID: 32640905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.